About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,591 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,591 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4901-4920 of 6,591 trials

Active not recruitingLong-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T CellsThe purpose of this study is to assess long-term side effects from subjects who receive an Adicet Bio γδ CAR T cell product.NCT04911478·Palo Alto, California and 4 others CompletedResiliency in Older Adults Undergoing Bone Marrow TransplantThe objective of this research is to measure certain indicators of resiliency to better understand which participants who are over 60 years old will respond more positively to…NCT04188678·Baltimore, Maryland RecruitingHM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZLThe study follows a Simon's two-stage phase II trial design to evaluate the safety and efficacy of tafasitamab added to rituximab and lenalidomide for two treatment-naïve…NCT06792825·Minneapolis, Minnesota

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

UnknownChidamide With CHOP Regimen for de Novo PTCL Patients (CHOP: Cyclophosphamide, Etoposide, Vincristine and Prednisone; PTCL: Peripheral T Cell Lymphoma)This study evaluates the efficacy and safety of Chidamide plus CHOP regimen for de novo PTCL patients.NCT03268889·Suzhou, Jiangsu

UnknownA Study on Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive B-LymphomaTumour lysis syndrome (TLS) occurs as a consequence of the rapid destruction of malignant cells, spontaneously and/or in response to cytotoxic agents and immunotherapies.NCT05840289·Geneva

WithdrawnAprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With CancerRATIONALE: Antiemetic drugs, such as aprepitant and ondansetron, may help lessen nausea and vomiting caused by opioids.NCT00499668

RecruitingMyeloablative Allo HSCT With Related or Unrelated Donor for Heme DisordersThis is a Phase II study of allogeneic hematopoietic stem cell transplant (HCT) using a myeloablative preparative regimen (of either total body irradiation (TBI); or…NCT03314974·Minneapolis, Minnesota

CompletedAssessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070JRATIONALE: Studying bone marrow and blood samples from patients with leukemia or lymphoma treated with arsenic trioxide may help doctors learn more about cancer.NCT00899015

Enrolling by invitationLong-term Study to Evaluate Safety and Persistence of GF-CART01The goal of this observational study is to learn about the long-term safety of GF-CART01 after cell infusion up to 15 years.NCT06985576·Taipei

CompletedA Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in ChinaThe purpose of this study is to learn about the safety and what the body does to the medicine (Maplirpacept) when taken for the treatment of non-Hodgkin lymphoma or multiple…NCT05896774·Beijing, Beijing Municipality and 4 others

RecruitingMogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary SyndromeThe purpose of this study is to determine the efficacy of the combination of LD-TSEBT and mogamulizumab in patients with MF and SS.NCT04256018·Stanford, California

CompletedBendamustine/Lenalidomide/Rituximab: Combination as a Second-Line Therapy for 1st Relapsed-Refractory MCLThis is a prospective, multicenter phase II trial designed to evaluate the safety and activity of the combination of Bendamustine, Lenalidomide and Rituximab (R2-B) in patients…NCT01737177·Trani, Barletta-Andria-Trani (BT) and 42 others

RecruitingA Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological MalignanciesA Study of Murine CD19 CAR-T Cells Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies.NCT04532281·Hangzhou, Zhejiang

TerminatedCollecting and Studying Tissue Samples From Patients With HIV-Associated MalignanciesRATIONALE: Collecting and studying tissue samples from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers…NCT01567722·La Jolla, California and 13 others

CompletedIbrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaThis phase I trial studies the side effects and best dose of ibrutinib when given together with rituximab, ifosfamide, carboplatin, and etoposide (combination chemotherapy) in…NCT02219737·New York, New York

Active not recruitingLong-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood CancersThe purpose of this study is to find out more about the long-term safety of pirtobrutinib in participants with previously treated types of blood cancer.NCT07162181·Beijing and 5 others

TerminatedBI 695500 vs Rituxan First Line Treatment in Patients With Low Tumor Burden Follicular LymphomaThis is a Phase III, multicenter, randomized, double-blind, parallel-arm, active comparator trial to evaluate BI 695500 versus rituximab as a first-line immunotherapy treatment in…NCT02417129·Muscle Shoals, Alabama and 20 others

RecruitingAllogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell LymphomasRelapsed and refractory T-cell lymphomas have been reported to have dismal outcomes. The role of allogeneic stem cell transplantation have been demonstrated in these patients.NCT02859402·Busan and 1 other

Active not recruitingHuman AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid MalignanciesThe purpose of this study is to determine if it is possible to treat relapsed or refractory lymphoid malignancies (Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic…NCT04732845·Cleveland, Ohio

CompletedCAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI)This was a Retrospective cohort study based on the PMSI data sourceNCT05349201·East Hanover, New Jersey

PreviousPage 246 of 330Next